US Patent 10253083 Therapeutic uses of modified relaxin polypeptides
Patent 10253083 was granted and assigned to Ambrx on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 21, 2016
Date of Patent
April 9, 2019
Patent Applicant
Patent Application Number
15386347
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10253083 Therapeutic uses of modified relaxin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
